Proliferation characteristics of canine transmissible venereal tumor

Anticancer Research

Volumn 21, Issue 6 A, 2001, Pages 4017-4024

  Chu, Rea Min ^a   Lin, Ching Yi ^a   Liu, Cheng Chi ^a   Yang, Shin Yi ^a   Hsiao, Ya Wen ^a   Hung, Shao Wen ^a   Pao, Hai Ni ^a   Liao, Kuang Wen ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

AgNOR; PCNA; Proliferation; Telomerase activity; Transmissible venereal tumor; TUNEL stain

Indexed keywords

CYCLINE; CYTOKINE; TELOMERASE;

ANIMAL CELL; ANIMAL DISEASE; ANIMAL MODEL; ANIMAL VENEREAL TUMOR; ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CHROMOSOME NOR; DOG; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; NONHUMAN; PRIORITY JOURNAL; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; TUMOR CELL;

ANIMALS; CELL DIVISION; DOG DISEASES; DOGS; NEOPLASMS; NUCLEOLUS ORGANIZER REGION; PROLIFERATING CELL NUCLEAR ANTIGEN; SEXUALLY TRANSMITTED DISEASES; TELOMERASE;

EID: 0035571183     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. The transmissible venereal tumor of dogs: Observations on forty generations of experimental transfer
2. Successively transplanted canine transmissible sarcoma
3. Isolation and characterization of canine venereal tumor-associated inhibition and blocking factors
4. Metastatic transmissible venereal sarcoma in a dog
5. Metastatic transmissible venereal tumor in the dog
6. Transmissible venereal tumor: A retrospective study of 29 cases
7. Implantation of canine transmissible sarcoma cells to x-ray - Irradiated and nude mice
8. "Retroposon" insertion into the cellular oncogene cmyc in canine transmissible venereal tumor
9. Molecular structure of canine LINE-1 elements in canine transmissible venereal tumor
10. Heat shock proteins in canine transmissible venereal tumor
11. Telomere loss: Mitotic clock or genetic time bomb?
12. Telomere length predicts replicative capacity of human fibroblasts
13. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity
14. Absence of cancer-associated changes in human fibroblasts immortalized with telomerase
15. Telomerase in the early detection of cancer
16. Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro
17. Evaluation of an assay for detecting telomerase activity in neoplastic tissues of dogs
18. Measurement of telomerase activity in dog tumors
19. How should we count AgNORs? Proposals for a standardized approach
20. Cell proliferation assessment in oncology
21. Frequency of argyrophilic nucleolar organizer regions in fine-needle aspirates and biopsy specimens from mast cell tumors in dogs
22. An improved system for quantifying AgNOR and PCNA in canine tumors
23. Correlation of Ag-NOR protein measurements with prognosis in canine transmissible venereal tumour
24. The yeast analog of mammalian cyclin/proliferating cell nuclear antigen interacts with mammalian DNA polemerase delta
25. The assessment of cellular proliferation by immunohistochemistry: A review of currently available methods and their applications
26. Detection of telomerase activity in malignant and nonmalignant skin conditions
27. Canine transmissible venereal sarcoma: Transplantation studies in neonatal and adult dogs
28. Measurement of the rate of death of canine transmissible venereal tumour cells transplanted into dogs and nude mice
29. Restoration of MHC class I surface expression and endogenous antigen presentation by a molecular chaperone
30. Characterization of the major histocompatibility complex class I deficiencies in B16 melanoma cells
31. Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression
32. Mechanism of major histocompatibility complex expression in canine transmissible venereal tumor cells during tumor regression
33. Clinical implications of telomerase in cancer
34. Telomerase activity in hematopoietic cells is associated with self-renewal potential
35. Tales of tails: Regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging
36. Telomerase activity concentrates in the mitotically active segments of human hair follicles
37. Telomerase activity in pancreatic endocrine tumours: A potential marker for malignancy
38. Telomerase assay for differentiating between malignancy-related and nonmalignant ascites
39. Cellular prolilerative and telomerase activity in canine mammary gland tumors
40. Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma
41. Development of retinoblastoma in the absence of telomerase activity
42. Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: Correlation with grade, histology, and proliferative activity
43. Telomerase activity does not always imply telomere maintenance
44. Characterization of the proliferation state in canine mammary tumors by the standardized AgNOR method with postfixation and immunohistologic detection of Ki-67 and PCNA
45. Proliferating cell nuclear antigen (PCNA) and nucleolar organizer regions in Hodgkin's disease: Correlation with morphology
46. Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle. Association with DNA replication sites
47. Canine transmissible venereal tumour: A morphological and immunohistochemical study of 11 tumours in growth phase and during regression after chemotherapy